Tocqueville Asset Management L.P. Sells 620 Shares of Clorox Co (NYSE:CLX)

Tocqueville Asset Management L.P. trimmed its stake in Clorox Co (NYSE:CLX) by 25.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,775 shares of the company’s stock after selling 620 shares during the quarter. Tocqueville Asset Management L.P.’s holdings in Clorox were worth $240,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of CLX. Oppenheimer Asset Management Inc. increased its stake in shares of Clorox by 1.6% in the second quarter. Oppenheimer Asset Management Inc. now owns 23,638 shares of the company’s stock worth $3,197,000 after purchasing an additional 383 shares in the last quarter. Advisor Partners LLC grew its stake in Clorox by 10.8% during the second quarter. Advisor Partners LLC now owns 4,172 shares of the company’s stock valued at $564,000 after acquiring an additional 408 shares in the last quarter. First Midwest Bank Trust Division grew its stake in Clorox by 2.5% during the second quarter. First Midwest Bank Trust Division now owns 17,026 shares of the company’s stock valued at $2,303,000 after acquiring an additional 412 shares in the last quarter. Texas Yale Capital Corp. grew its stake in Clorox by 3.5% during the second quarter. Texas Yale Capital Corp. now owns 12,430 shares of the company’s stock valued at $1,681,000 after acquiring an additional 415 shares in the last quarter. Finally, Chemical Bank grew its stake in Clorox by 4.1% during the second quarter. Chemical Bank now owns 10,910 shares of the company’s stock valued at $1,475,000 after acquiring an additional 425 shares in the last quarter. Institutional investors and hedge funds own 78.36% of the company’s stock.

In related news, SVP Michael R. Costello sold 9,265 shares of the company’s stock in a transaction on Monday, August 13th. The shares were sold at an average price of $140.02, for a total transaction of $1,297,285.30. Following the completion of the sale, the senior vice president now directly owns 34,293 shares in the company, valued at approximately $4,801,705.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Linda J. Rendle sold 382 shares of the company’s stock in a transaction on Thursday, September 6th. The shares were sold at an average price of $148.32, for a total transaction of $56,658.24. The disclosure for this sale can be found here. Insiders have sold a total of 29,268 shares of company stock valued at $4,196,686 over the last quarter. 1.00% of the stock is currently owned by company insiders.

Shares of CLX traded up $3.00 during mid-day trading on Friday, reaching $149.58. The company’s stock had a trading volume of 1,559,896 shares, compared to its average volume of 1,205,527. The firm has a market cap of $19.21 billion, a price-to-earnings ratio of 23.89, a PEG ratio of 3.11 and a beta of 0.36. The company has a debt-to-equity ratio of 3.15, a quick ratio of 0.67 and a current ratio of 1.09. Clorox Co has a 52 week low of $113.57 and a 52 week high of $153.38.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 2nd. The company reported $1.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.58 by $0.08. Clorox had a net margin of 13.44% and a return on equity of 103.18%. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.72 billion. During the same period in the previous year, the business posted $1.53 EPS. The business’s quarterly revenue was up 2.7% on a year-over-year basis. As a group, equities research analysts predict that Clorox Co will post 6.41 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Investors of record on Wednesday, October 31st will be issued a dividend of $0.96 per share. The ex-dividend date is Tuesday, October 30th. This represents a $3.84 dividend on an annualized basis and a yield of 2.57%. Clorox’s dividend payout ratio is currently 61.34%.

CLX has been the subject of several recent analyst reports. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research note on Wednesday. Argus upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $175.00 target price for the company in a research report on Tuesday, September 25th. ValuEngine upgraded shares of Clorox from a “hold” rating to a “buy” rating in a research report on Saturday, September 22nd. BMO Capital Markets reiterated a “buy” rating and set a $153.00 target price on shares of Clorox in a research report on Friday, August 3rd. Finally, Atlantic Securities assumed coverage on shares of Clorox in a research report on Thursday, September 20th. They set a “neutral” rating and a $151.00 target price for the company. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $136.53.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: Using the New Google Finance Tool

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply